VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 26 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $7,000 | +40.0% | 7,000 | 0.0% | 0.00% | – |
Q2 2019 | $5,000 | -44.4% | 7,000 | 0.0% | 0.00% | – |
Q1 2019 | $9,000 | -18.2% | 7,000 | 0.0% | 0.00% | – |
Q4 2018 | $11,000 | +10.0% | 7,000 | 0.0% | 0.00% | – |
Q3 2018 | $10,000 | -9.1% | 7,000 | -12.5% | 0.00% | – |
Q2 2018 | $11,000 | – | 8,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GSA CAPITAL PARTNERS LLP | 5,095,354 | $525 | 0.06% |
TKG Advisors, LLC | 134,860 | $13,891 | 0.01% |
GPS Wealth Strategies Group, LLC | 253,205 | $25,321 | 0.01% |
Performa Ltd (US), LLC | 70,000 | $7,210 | 0.00% |
Genesee Capital Advisors, LLC | 19,860 | $2,046 | 0.00% |
Garden State Investment Advisory Services LLC | 30,000 | $3,090 | 0.00% |
MAI Capital Management | 617,733 | $63,626 | 0.00% |
Twin Lakes Capital Management, LLC | 12,500 | $1,288 | 0.00% |
DRIVE WEALTH MANAGEMENT, LLC | 10,000 | $1,030 | 0.00% |
Boyd Wealth Management, LLC | 12,180 | $1,255 | 0.00% |